Company Overview
Company Type: Public Company
Website: www.nanalysis.com
Number of Employees: 249
Ticker: NSCI (TSXV)
Year Founded: -


Business Description
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K’Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries. The company is headquartered in Calgary, Canada.

Financial Information (Currency: CAD, in mm) 
Total Revenue
25.7
Market Capitalization
46.1
TEV/Total Revenue
2.8x
EBITDA
(15.6)
Total Enterprise Value
71.7
TEV/EBITDA
NM
EBIT
(15.2)
Cash & ST Invst.
5.0
P/Diluted EPS Before Extra
NM
Net Income
(13.1)
Total Debt
18.6
Price/Tang BV
3.0x
Capital Expenditure
(1.1)
Total Assets
72.4
Total Debt/EBITDA
NM
Currency in CAD in mm, LTM as of Jun-30-2023 TEV and Market Cap are calculated using a close price as of Oct-04-2023


Estimates Snapshot (Current Fiscal Year End: Dec-31-2023 | Currency: CAD)
Periodic Estimates
Current FQ
Current FQ+1
Current FY
Current FY+1
NTM
EPS Normalized
(0.02)
(0.02)
(0.12)
-
-
Revenue (mm)
8.70
11.30
31.70
-
-
EBITDA (mm)
(0.50)
(0.10)
(6.50)
-
-

Forward Multiples (Current FY)

Price/Earnings
NM
TEV/REV
2.26x
TEV/EBITDA
NM

Non-Periodic Estimates

Recommendation
Buy (1.00)
Target Price
1.40
Potential Upside
207.69%


Key Professionals
Name
Title
Burian, Martin Andrew
Corporate Secretary & Independent Chairman
Krakiwsky, Sean 
Founder, CEO, President & Director
McRae, Randall 
Corporate Controller & CFO
Phillips, Heather 
Vice President of Operations
Muller, Julien 
Chief Technology Officer
Selinger, Matthew 
Investor Relations Manager
Riegel, Susanne 
Vice President of Marketing & Product Manager
Lin, Kham 
MD of Security Business & Director
McFeetors, Greg 
Head of Manufacturing
Borkowsky, Robert 
Executive Officer

Key Board Members
Name
Title
Burian, Martin Andrew
Corporate Secretary & Independent Chairman
Krakiwsky, Sean 
Founder, CEO, President & Director
Lin, Kham 
MD of Security Business & Director
Gartner, Werner 
Independent Director
Okoniewski, Michal 
Independent Director
Cloetens, Guido 
Independent Director
Lenggenhager, Rene 
Independent Director
Mueller, Len 
Member of Scientific Advisory Board
Rosen, Matt 
Member of Scientific Advisory Board
Sakellariou, Dimitrios 
Member of Scientific Advisory Board
Starewiz, Piotr 
Member of Scientific Advisory Board


Primary Industry Classification
Health Care Equipment


Primary Office Location
Bay 1, 4600 5th Street NE | Calgary, AB | T2E 7C3 | Canada
Phone: 403 769 9499   Fax: 403 775 6683

Current and Pending Investors
NameSilo Technologies Corp. (OTCPK:URLO.F)

Stock Quote and Chart (Currency: CAD)
Last  (Delayed)
 0.44
Market Cap (mm)
46.1
Open
 0.46
Shares Out. (mm)
101.4
Previous Close
 0.46
Float %
92.7%
Change on Day
(0.02)
Shares Sold Short (mm)
-
Change % on Day
(4.4)%
Dividend Yield %
-
Day High/Low
 0.46/ 0.43
Diluted EPS Excl. Extra Items
(0.14)
52 wk High/Low
 0.85/ 0.42
P/Diluted EPS Before Extra
NM
Volume (mm)
0.03
Avg 3M Dly Vlm (mm)
0.03
Beta 5Y
0.91


 
Delayed Quote** | Last Updated on Oct-05-2023 01:22 PM (GMT-5)
TSXV:NSCI - Common Stock


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Current and Pending Subsidiaries / Investments
Company Name
Business Description
Geography
Primary Industry
LTM Total Rev.($mm)
LFQ Total Assets ($mm)
LFQ Total Debt ($mm)
K'(Prime) Technologies Inc.
K'(Prime) Technologies Inc. distributes laboratory instrumentation and supplies. The company was founded in 1997 and is based in Calgary, Canada. As of January 11, 2022, K'(Prime) Technologies Inc. operates as a subsidiary of Nanalysis Scientific Corp.

United States and Canada
Trading Companies and Distributors
8.00
-
-
One Moon Scientific, Inc.
One Moon Scientific, Inc. develops a software for nuclear magnetic resonance (NMR) analysis. The company was incorporated in 2014 and is based in New York, New York. One Moon Scientific, Inc. operates as a subsidiary of Nanalysis Scientific Corp. As of July 28, 2021, One Moon Scientific, Inc. operates as a subsidiary of Nanalysis Scientific Corp.

United States and Canada
Application Software
-
-
-
RS2D SAS
RS2D SAS manufactures electronics components for magnetic resonance imaging (MRI) and nuclear magnetic resonance (NMR) systems. The company was founded in 2004 and is based in Mundolsheim, France.

Europe
Electronic Components
-
-
-
Canvass Ventures Ltd.
As of June 4, 2019, Canvass Ventures Ltd. was acquired by Nanalysis Corp., in a reverse merger transaction. Canvass Ventures Ltd. does not have significant operations. It intends to identify and evaluate companies, assets, or businesses with a view to completing a qualifying transaction. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

United States and Canada
Asset Management and Custody Banks
-
0.00
0.00
QUAD SYSTEMS AG
QUAD SYSTEMS AG develops, manufacturers, integrates, and sells components for nuclear magnetic resonance spectrometers. It offers compact magnets, standard and customized probes, and high-end consoles. The company was incorporated in 2020 and is based in Dietlikon, Switzerland with sales and support offices worldwide.

Europe
Electrical Components and Equipment
-
-
-


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Apr-21-2023
May-03-2023
Private Placement
Target
Nanalysis Scientific Corp. (TSXV:NSCI)


3.03
Jan-27-2022
Feb-10-2022
Private Placement
Target
Nanalysis Scientific Corp. (TSXV:NSCI)


2.29
Jan-20-2022
Feb-11-2022
Public Offering
Target
Nanalysis Scientific Corp. (TSXV:NSCI)


8.46
Jan-18-2022
-
Private Placement
Buyer
QUAD SYSTEMS AG
Nanalysis Scientific Corp. (TSXV:NSCI)

7.09
Dec-15-2021
-
Private Placement
Target
Nanalysis Scientific Corp. (TSXV:NSCI)


0.16
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Sep-06-2023
Company Conference Presentations
Nanalysis Scientific Corp. Presents at Planet MicroCap Showcase: VANCOUVER 2023, Sep-06-2023 09:30 AM
Aug-25-2023
Earnings Calls
Nanalysis Scientific Corp., Q2 2023 Earnings Call, Aug 25, 2023
Aug-24-2023
Earnings Calls
Nanalysis Scientific Corp., Q2 2023 Earnings Call, Aug 24, 2023
Jun-28-2023
Shareholder/Analyst Calls
Nanalysis Scientific Corp. - Shareholder/Analyst Call
Jun-28-2023
Annual General Meeting
Nanalysis Scientific Corp., Annual General Meeting, Jun 28, 2023

Competitors
Bruker Corporation (NasdaqGS:BRKR), General Electric Company (NYSE:GE), JEOL Ltd. (TSE:6951), Koninklijke Philips N.V. (ENXTAM:PHIA), Magritek Inc, MR Solutions Limited, Oxford Instruments America, Inc., Revvity, Inc. (NYSE:RVTY), Shimadzu Corporation (TSE:7701), Siemens Aktiengesellschaft (XTRA:SIE), Techflow, Inc., Thermo Fisher Scientific Inc. (NYSE:TMO)

M&A Advisors
DLA Piper (Canada) LLP


Advisors
Most Recent Auditor
Ernst & Young LLP
M&A Advisors
DLA Piper (Canada) LLP
Public Offering Advisors
DLA Piper (Canada) LLP, Ernst & Young LLP (Canada)


Most Recent Auditor
Ernst & Young LLP


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
Echelon Wealth Partners Inc.
Quenneville, Stefan
Aug 25, 2023 04:48 AM
NSCI
NSCI - Solid Q223 as CATSA Contribution More Than Makes Up for NMR Weakness; Maintaining Buy Rating and PT
Notes
6
Smart Insider Ltd.

Jul 03, 2023 03:37 AM
NSCI
NetScientific: 2 directors
Reporting Results*
1
Echelon Wealth Partners Inc.
Quenneville, Stefan
May 26, 2023 05:31 AM
NSCI
NSCI - Big Q1 Miss as NMR Business Underperforms Due to Mgmt. Focus on CATSA; Lowering PT but Maintaining Buy Rating
EPS Estimates*
6
Wright Investors' Service Inc.

May 24, 2023 01:41 AM
NSCI
Flow of Funds Report for Nanalysis Scientific Corp. - prepared by Wright Investors Service
Notes
66
Echelon Wealth Partners Inc.
Quenneville, Stefan
Apr 28, 2023 06:02 AM
NSCI
NSCI - Results Impacted by CATSA Contract Roll-Out Challenges, Masking Solid Benchtop NMR Business Strength; Maintaining Buy Rating, $1.90 PT
Notes
6
Echelon Wealth Partners Inc.
Quenneville, Stefan
Apr 24, 2023 05:19 AM
NSCI
NSCI - Financing Bolsters Balance Sheet but Signals Bumpy CATSA Roll-Out; Lowering Price Target to $1.90 (from $2.75); Maintaining Buy Rating
EPS Estimates*
5
Echelon Wealth Partners Inc.
Quenneville, Stefan
Oct 20, 2022 09:57 AM
NSCI
NSCI - Pre-Announced Q3 Revenues Beat Expectations, Growth Trajectory Back on Track After Tough Q2; Maintaining Buy Rating, $2.75 PT
EPS Estimates*
5
Echelon Wealth Partners Inc.
Quenneville, Stefan
Aug 26, 2022 10:29 AM
NSCI
NSCI - Disappointing Q2 on Salesforce Realignment; Maintaining Buy Rating, But Trimming PT to $2.75 (from $3.25) on Tempered Growth Outlook
Reporting Results*
6
Research Capital Corporation
Ma, Yue
Jun 01, 2022 05:16 AM
NSCI
Q1 Results - Continuing Delivering The Goods
EPS Estimates*
7
Echelon Wealth Partners Inc.
Quenneville, Stefan
May 31, 2022 02:47 PM
NSCI
NSCI - Slight Q1 Miss Despite Impressive Growth; Positive Outlook Supported by Recent $160M Contract Win; Maintaining Buy Rating, $3.25 PT
Reporting Results*
6


Ownership Summary

            Top Holders 
Holders by Type
Holder

Common Stock Equivalent Held

% of Total Shares Outstanding

Market Value (CAD in mm)

Position Date


Lin Holdings Inc.

2,843,000

2.80

1.3

May-31-2023


Krakiwsky M.Sc., Sean 

1,247,429

1.23

0.6

May-31-2023


Okoniewski, Michal 

1,117,500

1.10

0.5

May-31-2023


Burian CPA, CA, CPA, Martin Andrew

872,300

0.86

0.4

May-31-2023


Gartner C.M.A., CPA, Werner 

796,385

0.79

0.4

May-31-2023


Muller, Julien 

243,247

0.24

0.1

Dec-31-2022


Lenggenhager Ph.D., Rene 

150,000

0.15

0.1

May-31-2023


Cloetens, Guido 

98,750

0.10

0.0

Jul-10-2023


MAI Capital Management, LLC

30,000

0.03

0.0

Jun-30-2023


Venator Capital Management Ltd.

0

0.00

0.0

Jun-30-2023



 



Top Buyers
Buyers
Common Stock Equivalent Held
Change
Lin Holdings Inc.
2,843,000
83,000
Krakiwsky M.Sc., Sean 
1,247,429
83,000
Burian CPA, CA, CPA, Martin Andrew
872,300
83,000
Okoniewski, Michal 
1,117,500
50,000

Top Sellers
Sellers
Common Stock Equivalent Held
Change
Venator Capital Management Ltd.
0
(275,300)
Cloetens, Guido 
98,750
(25,000)


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
No News is currently available for the selected sources.


Company Coverage
This company is not on any Coverage List.

Products
NMReady-60, Spectrometers


Upcoming Events
Date/Time
Type
Nov-24-2023
Estimated Earnings Release Date (S&P Global Derived)
* Future Events are subject to change.


Recent Major Filings

Key Filings
Filed On
Period Date
Company Name
Source
Form Type
Size
Aug-30-2023
-
Nanalysis Scientific Corp. (TSXV:NSCI)
SEDAR
News Releases
35 KB
Aug-24-2023
-
Nanalysis Scientific Corp. (TSXV:NSCI)
SEDAR
News Releases
47 KB
Aug-24-2023
Jun-30-2023
Nanalysis Scientific Corp. (TSXV:NSCI)
SEDAR
Interim Financial Statements
804 KB
Aug-15-2023
-
Nanalysis Scientific Corp. (TSXV:NSCI)
SEDAR
News Releases
36 KB
Jun-29-2023
-
Nanalysis Scientific Corp. (TSXV:NSCI)
SEDAR
News Releases
40 KB
Jun-20-2023
-
Nanalysis Scientific Corp. (TSXV:NSCI)
SEDAR
News Releases
36 KB
Jun-15-2023
-
Nanalysis Scientific Corp. (TSXV:NSCI)
SEDAR
News Releases
35 KB
Jun-07-2023
-
Nanalysis Scientific Corp. (TSXV:NSCI)
SEDAR
Management Proxy Materials
126 KB
Jun-07-2023
-
Nanalysis Scientific Corp. (TSXV:NSCI)
SEDAR
Management Proxy Materials
147 KB
Jun-07-2023
-
Nanalysis Scientific Corp. (TSXV:NSCI)
SEDAR
Management Proxy Materials
96 KB


Insider Trades
Holder Name
Trade Date Range
Security Type
Transacted Shares
Transaction Value Range (CAD)
Transaction Type
% Change
Source
Cloetens, Guido  (Independent Director)
Jul-10-2023
Common Shares
(25,000)
(15,507)
Open Market Disposition
(20.20)
Multiple
Cloetens, Guido  (Independent Director)
Jul-10-2023
Common Shares
20,000
0
Derivative Exercise and Retained Stock
25.40
Multiple
Cloetens, Guido  (Independent Director)
Jul-07-2023
Common Shares
(20,000)
(10,538)
Open Market Disposition
(16.16)
Multiple
Cloetens, Guido  (Independent Director)
May-19-2023
Common Shares
20,000
-
Other Acquisition
19.28
Multiple
Cloetens, Guido  (Independent Director)
May-19-2023
Common Shares
(20,000)
-
Other Disposition
(13.91)
Multiple
Excluding Automatic Transactions
Key Board Members Details
Name
Title
Phone
Fax
Email
Burian, Martin Andrew
Corporate Secretary & Independent Chairman
(778) 373-1562
403 775 6683
martin@burian.ca
Krakiwsky, Sean 
Founder, CEO, President & Director
+1.587.436.1291
403 775 6683
sean.krakiwsky@nanalysis.com
Lin, Kham 
MD of Security Business & Director
403 769 9499
403 775 6683

Gartner, Werner 
Independent Director
403 769 9499
403 775 6683

Okoniewski, Michal 
Independent Director
403 769 9499
403 775 6683

Cloetens, Guido 
Independent Director
(604) 997-8011
403 775 6683

Lenggenhager, Rene 
Independent Director
403 769 9499
403 775 6683

Mueller, Len 
Member of Scientific Advisory Board
403 769 9499
403 775 6683

Rosen, Matt 
Member of Scientific Advisory Board
403 769 9499
403 775 6683

Sakellariou, Dimitrios 
Member of Scientific Advisory Board
403 769 9499
403 775 6683

Starewiz, Piotr 
Member of Scientific Advisory Board
403 769 9499
403 775 6683

* denotes that the relationship is proprietary

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Burian, Martin Andrew
Corporate Secretary & Independent Chairman
(778) 373-1562
403 775 6683
martin@burian.ca
Krakiwsky, Sean 
Founder, CEO, President & Director
+1.587.436.1291
403 775 6683
sean.krakiwsky@nanalysis.com
McRae, Randall 
Corporate Controller & CFO
403 769 9499
403 775 6683

Phillips, Heather 
Vice President of Operations
403 769 9499
403 775 6683

Muller, Julien 
Chief Technology Officer
403 769 9499
403 775 6683

Selinger, Matthew 
Investor Relations Manager
+1.415.572.8152
403 775 6683
matthew.selinger@nanalysis.com
Riegel, Susanne 
Vice President of Marketing & Product Manager
403 769 9499
403 775 6683

Lin, Kham 
MD of Security Business & Director
403 769 9499
403 775 6683

McFeetors, Greg 
Head of Manufacturing
403 769 9499
403 775 6683
-
Borkowsky, Robert 
Executive Officer
403 769 9499
403 775 6683

* denotes that the relationship is proprietary

Historical Equity Pricing Data supplied by Interactive Data Pricing and Reference Data LLC 
S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 

**Intraday Quotes are delayed by at least 20 minutes.
